1.2Small cell lung cancer The main forms of lung cancer includesmall cell lung cancer(SCLC)[3]and non-small cell lung cancer (NSCLC)[2]. Small cell lung cancer is an aggressive disease that accounts for 10–15% of all lung cancers. Metastases to regional lymph nodes or distant site...
Department of Medical Oncology, Christie Hospital NHS Trust, Manchester, UK. roberta_ferraldeschi@yahoo.comThatcher,NLorigan,PExpert Rev Anticancer TherFerraldeschi R, Thatcher N, Lorigan P. Pemetrexed in small cell lung cancer: an overview of the background and review of the ongoing GALES (...
Although small cell lung cancer (SCLC) is treated as a homogeneous disease, biopsies and preclinical models reveal heterogeneity in transcriptomes and morphology. SCLC subtypes were recently defined by neuroendocrine transcription factor (NETF) expressio
Circulating tumor cells from patients with small-cell lung cancer can form tumors in mice, and their derived explants recapitulate the patients' response to chemotherapy. Small-cell lung cancer (SCLC), an aggressive neuroendocrine tumor with early dissem
Worldwide, non-small-cell lung cancer (NSCLC) is a leading cause of cancer-related mortality and, until screening detects early disease, treatment for the ... Onn,A.,Tsuboi,... - 《British Journal of Cancer》 被引量: 50发表: 2004年 The First Two Years of Practice: A Longitudinal Persp...
Small cell lung cancer (SCLC) represents approximately 13% of all lung cancer diagnoses and the incidence has reduced over the last 20 years. Treatment of
small cell lung cancertreatmentAbstract: Lung cancer was relatively uncommon at the turn of the 20th century, and has increased in prevalence at alarming rates, particularly because of the augmented trend in smoking, so that it is now the most common cause of cancer death in the world. ...
(2015) Nhs-il2 combined with radiotherapy: Preclinical rationale and phase ib trial results in metastatic non-small cell lung cancer following first-line chemotherapy. J Transl Med 13: 32.Michel M, van den HeuvelMarcel, VerheijRogier, BoshuizenJos茅, BelderbosAnne-Marie C, DingemansDirk, De Ru...
Pemetrexed for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) 来自 hta.nhs.uk 喜欢 0 阅读量: 35 作者: B Hill 摘要: interaction and corresponding subgroup analyses. Cost-effectiveness analysis results expressedas incremental cost per QALY gained. A...
Chemotherapy of non-small cell lung cancer in the elderly. Around one-third of all patients with non-small cell lung cancer (NSCLC) are over the age of 70. Elderly patients tolerate chemotherapy poorly because of i... Gridelli,Cesare - 《Lung Cancer》 被引量: 33发表: 2002年 Neoadjuvant ...